Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Virus Protease
    (1)
  • iGluR
    (1)
  • Others
    (2)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FCM
    (1)
  • Functional assay
    (1)
TargetMol | Tags By ResearchField
  • Infection
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

adci

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • ADCI
    SGB-017, SGB017, SGB 017
    T26564124070-15-1
    ADCI is an inhibitor of voltage-activated sodium channels and N-methyl-D-aspartate (NMDA)-receptor-gated channels. Inhibition of sodium channels by ADCI was voltage dependent. High doses of ADCI increased dopamine metabolism in the prefrontal cortex and/o
    • $1,820
    8-10 weeks
    Size
    QTY
  • Odesivimab
    REGN-3471, REGN3471
    T771052135632-30-1
    Odesivimab (REGN-3471) is a humanized monoclonal antibody that specifically targets the Ebola virus glycoprotein (GP). Odesivimab binds to the FcγRIIIa receptor on the surface of immune effector cells via its Fc region, inducing antibody-dependent cellular immunity (ADCI) to eliminate infected cells or viral particles, thereby exerting an antiviral effect. Odesivimab has a Kd value of 7.74 nM for the extracellular domain of the Ebola virus glycoprotein from the recombinant Makona strain.
    • $198
    In Stock
    Size
    QTY